| About the author: |
E. G. Sariyeva, I. A.Gafarov |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The choice of the correct treatment tactics for HBV, HCV-infections is based on biochemical and immunological indicators. In this regard, the development of programs on a mathematical basis can be considered a rational and correct approach to solving the diagnostic problem. The aim of the research was to assess the informativeness of additional laboratory indicators in the diagnosis of viral hepatitis B and C in pregnant women. The investigation included 150 pregnant women: the main group – 100 pregnant women with hepatitis B and C, the control group – 50 practically healthy pregnant women. Were carried out serological studies, polymerase chain reaction, biochemical, immunological blood tests. The results of the study showed that, among the studied indicators, apolipoprotein A1 and IgG have the highest sensitivity and overall diagnostic value, IgG, IgM and microglobulin-в2 have the highest specificity, and the indicators of microglobulin-b2, IgG and IgM. Apolipoprotein A1 and IgG have the highest negative efficacy scores. The ratio of the accuracy of positive and negative results allows the use of indicators of total cholesterol, apolipoprotein A1, low-density lipoproteins, microglobulin-в2, iron, C-reactive protein, IgG, IgM as auxiliary diagnostic biomarkers of infection of pregnant women with hepatitis B and C. |
| Tags |
pregnancy, HBV, HCV-infections, lipid metabolism indices, immunological biomarkers |
| Bibliography |
- Semenov AV. Molekulyarno-immunologicheskie markery porazheniya pecheni pri khronicheskikh virusnykh gepatitakh [dissertatsiya]. Sankt-Peterburg. 2017. 40 p. [In Russian]
- Chen L, Li W, Zhang K, Zhang R, Lu T, Hao M et al. Hepatitis C Virus RNA Real-Time Quantitative RT–PCR Method Based on a New Primer Design Strategy. The Journal of Molecular Diagnostics. 2016; 18 (1): 84–91. doi: 10.1016/j.jmoldx.2015.07.009. Epub 2015 Nov 21. PMID: 26612712.
- European Association for the Study of the Liver “EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection”. EASL Journal of Hepatology. 2017; 67: 370–398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18. PMID: 28427875.
- Fanshawe AE, Ibrahim M. The current status of lipoprotein (a) in pregnancy: a literature review. J Cardiol. 2013 Feb; 61(2):99–106. doi: 10.1016/j.jjcc.2012.09.009. Epub 2012 Nov 17. PMID: 23165148.
- Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015 Marth.166р. http://apps.who.int/iris/bitstream/handle/10665/154590/9789241549059_eng.pdf
- IBM SPSS 26 Step by Step: [Electronic resource] https: // routledgetextbooks.com/textbooks/9780367174354
- Kushner T, Terrault NA. Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care. Journal Hepatol Commun. 2019; 3 (1): 20–28. Published online 2018 Nov 30. doi: 10.1002/ hep4.1282
- Philip M EXCEL-2019. User guide. California: Independently published; 2019. 248p. ISBN-13: 978–1086. 365399. ISBN-10: 1086365399
- Sariyeva EG. Study of lipid spectrum indicators in blood pregnant women with chronic B, C virus hepatitis. East European Science Journal (Warsaw, Poland). 2019; 11(51): 40-50
- Terrault NA, Lok ASF, McMahon BJ, Chan K, Hwang JP, Jonas MM, et al. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B. AASLD 2018 Hepatitis B Guidance Practice guidance hepatology. 2018; 67: 1560–1599. doi: 10.1002/hep.29800. PMID: 29405329; PMCID: PMC5975958.
|
| Publication of the article |
«World of Medicine and Biology» №1(79), 2022 year, 121-126 pages, index UDK 616.9: 618.2-055 |
| DOI |
10.26724/2079-8334-2022-1-79-121-126 |
